Abstract
Neurofibromatosis 1 (NF1) is a genetic disease characterized by cutaneous, neurological and osseous complications. Although clinical manifestations of NF1 are variable, there has been no report on evaluation of severity in patients with NF1. To elucidate the grade of severity of NF1, a retrospective study was conducted in 124 NF1 patients at the Department of Dermatology of Tottori University Hospital in 2007-2016. The DNB classification (dermatological, neurological and bone manifestations) in Japan was used for assessment. Based on our current epidemiological data, there were 55 patients (44.3%) in stage 1, 23 (18.6%) in stage 2, three (2.4%) in stage 3, one (0.8%) in stage 4 and 42 (33.9%) in stage 5. The grade of severity in patients with NF1 tended to be higher with aging. Remarkably, 61.8% of the patients in stage 5 had diffuse plexiform neurofibromas with functional disability. We should pay attention to diffuse plexiform neurofibromas that greatly affect quality of life in patients with NF1.
References
Dec 1, 1991·Genomics·D A MarchukF S Collins
May 16, 1997·American Journal of Medical Genetics·J M Friedman, P H Birch
Jun 21, 2001·Neurology·M Ruggieri, S M Huson
Mar 20, 2002·Current Neurology and Neuroscience Reports·B R Korf
Oct 31, 2002·Journal of Child Neurology·J M Friedman
Jan 19, 2005·Archives of Dermatology·Marga LammertVictor F Mautner
Apr 7, 2005·Clinical Genetics·S AlwanJ M Friedman
May 22, 2007·Journal of Pediatric Orthopedics·Sukhdeep DulaiDavid G Little
Apr 5, 2012·Neuro-oncology·Michael J FisherGrant T Liu
Dec 19, 2012·Contemporary Clinical Trials·Kimberly J JohnsonDavid H Gutmann
Jul 22, 2014·The Journal of Dermatology·Katsumi TanitoMichihito Niimura
Oct 18, 2014·Genetic Testing and Molecular Biomarkers·Ryo MaruokaKenjiro Kosaki
Sep 5, 2015·Pediatric Dermatology·Maria Teresa García-RomeroIrene Lara-Corrales
Nov 14, 2015·Handbook of Clinical Neurology·Jacqueline L Anderson, David H Gutmann
Citations
Jun 3, 2020·The Journal of Dermatology·Yuichi YoshidaOsamu Yamamoto
Jul 7, 2019·Orphanet Journal of Rare Diseases·Takashi YamauchiHiroyuki Yanagisawa
Dec 19, 2019·The Journal of Dermatology·Yuko EharaYuichi Yoshida